Sort
21,453 grants matching “tuberculosis”
Structure, Function and Applications of Inteins
$300,025Tom W Muir · Princeton University · R01 · FY2010 · GM
Bacterial Division and the Dynamics of the Z-ring
$300,013Johns Hopkins University · R01 · FY2005 · GM
Heterocyclic Inhibitors of QcrB as Novel Drugs for Infections Caused by Nontuberculous Mycobacteria
$300,001Thomas Joseph Hannan · Fimbrion Therapeutics, Inc. · R43 · FY2025 · AI
Discovery of novel agents against M. tuberculosis.
$300,000Esteban Edward Mena · Lifepharms, Inc. · R43 · FY2010 · AI
Development of Broad-Spectrum Cyclic Amphiphilic Peptides against Multidrug-Resistant Bacteria
$300,000Assad Kazeminy · Ajk Biopharmaceutical Llc · R41 · FY2022 · AI
Potent Vaccine Adjuvant Therapeutic
$300,000Susan Dana Jones · Immurx Llc · R43 · FY2009 · AI
A New Tuberculin for the Diagnosis of Tuberculosis
$300,000Sequella, Inc. · R43 · FY2001 · AI
Validation of a new VL vaccine candidate in dogs that significantly protects mice
$300,000Claudia Abeijon · Detectogen, Inc. · R43 · FY2012 · AI
Development of an ELISA for serosurveillance of human hookworm
$300,000Andrew E. Levin · Kephera Diagnostics, Llc · R43 · FY2024 · AI
Wirelessly Observed Therapy to Monitor Treatment of Mycobacterium Tuberculosis
$300,000Lorenzo Dicarlo · Proteus Digital Health, Inc. · R43 · FY2013 · AI
A novel live intranasal TB vaccine
$300,000Frederick D Quinn · Pathens, Inc. · R41 · FY2012 · AI
Development of a Cytokine Release Assay as a Diagnostic Test for Lyme Disease
$300,000Paul Michael Arnaboldi · Biopeptides, Inc. · R43 · FY2012 · AI
GENETIC DISSECTION OF MYCOBACTERIAL INFECTION
$300,000Mcgill University · R01 · FY2002 · HL
A POINT OF CARE TEST FOR TUBERCULOSIS
$300,000Richard Baldwin · Nanocomposix, Inc. · N43 · FY2019 · AI
ELECTRONIC MONITORING OF COMPLIANCE WITH TB CHEMOTHERAPY
$300,000Sequella, Inc. · R43 · FY2000 · AI
Immuno-Chemotherapy to Shorten TB Treatment
$300,000Rhea N Coler · Pai Life Sciences, Inc. · R43 · FY2014 · AI
Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum
$300,000Shuren Zhu · Radix Pharmaceuticals, Inc. · R43 · FY2008 · AI
TRAINING PROGRAM IN TB AND HIV PREVENTION AND TREATMENT
$300,000New York University School Of Medicine · D43 · FY2000 · TW
Contribution of genetic variation to pharmacokinetic variability and toxicity in
$300,000Dissou Affolabi · Nat'L Hospital/Tuberculosis/Pul/Diseases · U01 · FY2012 · HG
Targeting MtrAB of M. tuberculosis
$300,000Marina N Protopopova · Sequella, Inc. · R41 · FY2012 · AI
New Agents for the Treatment on Mycobacteria Avium Infections
$300,000Dennis L Wright · Quercus Molecular Design, Llc · R41 · FY2023 · AI
Columbia University-Southern African AIDS International Training/Research Program
$300,000Quarraisha Abdool Karim · Columbia University Health Sciences · D43 · FY2011 · TW
Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
$300,000Thomas Joseph Hannan · Fimbrion Therapeutics, Inc. · R43 · FY2023 · AI
Alt-and-Renov
$300,000Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2019 · GM
GENETIC DISSECTION OF MYCOBACTERIAL INFECTION
$300,000Mcgill University · R01 · FY2004 · HL